(Medical Xpress)—One of the largest problems in clinical medicine is the growing prevalence of multidrug-resistant, disease-causing strains of Staphylococcus aureus. Penicillin resistance is now ...
January 8, 2007 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a test for the rapid detection of methicillin-resistant Staphylococcus aureus, a test for the detection of ...
Please provide your email address to receive an email when new articles are posted on . The FDA has announced the clearance of the first test to identify whether infections are methicillin-resistant ...
Antibiotics are the old medicine cabinet standby for treating infections caused by multidrug-resistant Staphylococcus aureus, but as antimicrobial resistance continues to mount globally, scientists ...
Clearance for these sample types will double the accessible market for KeyPath™ to more than 90% of U.S. hospitals. On May 6, 2011, MicroPhage received initial 510(k) clearance from the U.S. Food and ...
S. aureus bacteremia (SAB) remains a leading cause of sepsis, with mortality reaching 20–40% in complicated cases such as endocarditis 1. Clinical outcomes reflect a dynamic interplay between ...
A team of biologists and biomedical researchers at UC San Diego has developed a new method to determine if bacteria are susceptible to antibiotics within a few hours, an advance that could slow the ...
A research team discovers that silver (Ag)-based antimicrobials can effectively combat antibiotic resistant Staphylococcus aureus by targeting multiple biological pathways via functional disruption of ...
Methicillin-resistant Staphylococcus aureus (MRSA) is challenging modern antimicrobial therapy due to its high antimicrobial resistance. Nutraceuticals have gained a lot of interest and their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results